AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Optimizing LC-MS/MS for the TDM of Immunosuppressants - CD

Optimizing LC-MS/MS for the TDM of Immunosuppressants - CD
  • Copyright: 2013
  • Speaker: James Ritchie

Price: $119.00

Member Price: $99.00

This webcast originally aired as a live webinar sponsored by AACC and supported by a grant from Waters Corporation on May 14, 2013. More labs are bringing tandem mass spectrometry platforms in house to serve the needs of their hospitals and health systems that perform transplants or monitor transplant patients on immunosuppressant drugs. Health care organizations are also turning to LC-MS/MS as a viable alternative to immunoassay platforms for the analysis of immunosuppressant concentrations in transplant patients. View this program and learn about the advantages and disadvantages of using LC-MS/MS versus immunoassay for clinical measurement of immunosuppressants; hear information on standardization efforts related to mass spec-based assays for immunosuppressants such as cyclosporine, tacrolimus, and rapamycin; and understand the current thinking on monitoring newer drugs such as everolimus using LC-MS/MS.